Could your own blood cells tame MS? early trial shows promise
Disease control
Completed
This early-phase trial tested a new treatment for relapsing-remitting multiple sclerosis (RRMS) that uses a patient's own red blood cells. The cells are coated with specific peptides and given back to the patient to teach the immune system to stop attacking the body. The study in…
Phase: PHASE1 • Sponsor: Cellerys AG • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC